The EMA said people who had previously sustained capillary leak syndrome should not receive AstraZeneca’s Covid-19 vaccine. Photo: AFP The EMA said people who had previously sustained capillary leak syndrome should not receive AstraZeneca’s Covid-19 vaccine. Photo: AFP
The EMA said people who had previously sustained capillary leak syndrome should not receive AstraZeneca’s Covid-19 vaccine. Photo: AFP

Coronavirus: EU flags another rare blood condition as side effect of AstraZeneca vaccine

  • The European Medicines Agency’s safety committee said that capillary leak syndrome must be added as a new side effect to labelling on the shot
  • It said people who had previously sustained the condition should not receive the vaccine

Topic |   Coronavirus pandemic
The EMA said people who had previously sustained capillary leak syndrome should not receive AstraZeneca’s Covid-19 vaccine. Photo: AFP The EMA said people who had previously sustained capillary leak syndrome should not receive AstraZeneca’s Covid-19 vaccine. Photo: AFP
The EMA said people who had previously sustained capillary leak syndrome should not receive AstraZeneca’s Covid-19 vaccine. Photo: AFP
READ FULL ARTICLE